BioSpace News Archive

Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent.

Pfizer Inc. reported financial results for third-quarter 2020 and updated and tightened certain components of Total Company 2020 financial guidance, which continues to reflect actual and anticipated business impacts from the novel coronavirus disease of 2019 pandemic.

MyVeeva for Doctors app makes it easy for HCPs to access the people and resources they need to better treat patients

Rare pediatric disease and orphan drug designations now obtained in multiple pipeline programs, including TSHA-101 for GM2 gangliosidosis, TSHA-102 for Rett syndrome and TSHA-118 for CLN1

PROOF-HD is designed to replicate previous findings of pridopidine demonstrating maintenance of functional capacity in early Huntington’s Disease patients

Biopharmaceutical company Alvotech announced that its parent company, Alvotech Holdings SA, has successfully completed a $65 million private placement round.

Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins,today announced that two scientific manuscripts have been published in two leading journals

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced a new multi-indication gastrointestinal (GI) cancer study to be managed by AIO, a leading academic cooperative medical oncology group based in Germany.

Transparency Market Research has published a new report titled, ‘Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global histology & cytology market was valued at US$ 10.28 Bn in 2019 and is projected to expand at a CAGR of ~10% from 2020 to 2030.